Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation

Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients

(2012) P Hiwarkar et al.   BONE MARROW TRANSPLANTATION

Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease

(2011) Waseem Qasim et al.   BRITISH JOURNAL OF HAEMATOLOGY

How I treat adenovirus in hematopoietic stem cell transplant recipients

(2010) C. A. Lindemans et al.   BLOOD

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

(2010) K. S. Peggs et al.   CLINICAL INFECTIOUS DISEASES

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

(2009) A. M. Leen et al.   BLOOD

T-cell Lines Specific for Peptides of Adenovirus Hexon Protein and Devoid of Alloreactivity Against Recipient Cells can be Obtained From HLA-haploidentical Donors

(2009) Patrizia Comoli et al.   JOURNAL OF IMMUNOTHERAPY